Mylan CEO to testify before U.S. House over EpiPen pricing -lawmakers

WASHINGTON, Sept 14 (Reuters) - Mylan NL Chief
Executive Officer Heather Bresch will appear at a Sept. 21
congressional hearing over price increases for its allergy
auto-injector EpiPen, the U.S....